Overall, the technical outlook presents a balanced risk-reward scenario. While momentum indicators suggest improvement. The 200-day SMA remains a crucial benchmark, serving as a litmus test for the durability of Oracle’s recent recovery and its prospects for further gains.
Oracle’s upcoming earnings report is poised to be a defining moment for the company’s stock. The results will provide critical insights into whether the company’s substantial AI infrastructure expansion is sustainable.